The multiple functions of the endocannabinoid system: A focus on the regulation of food intake

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Tibiriça, Eduardo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID RECEPTOR; ENDOCANNABINOID; RIMONABANT;

ADIPOCYTE; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIMBIC SYSTEM; LIPID DIET; LIVER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; THALAMUS NUCLEUS; WEIGHT GAIN;

EID: 77953370532     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-5     Document Type: Review

References (42)

1. An archaeological and historical account of cannabis in China. HL Li H Lin, Econ Bot 1974 28 4 437 447
2. Plant, synthetic, and endogenous cannabinoids in medicine. V Di Marzo LD Petrocellis, Annu Rev Med 2006 57 553 74 10.1146/annurev.med.57.011205.135648 16409166
3. Cannabinoids in health and disease. NM Kogan R Mechoulam, Dialogues Clin Neurosci 2007 9 4 413 30 18286801
4. Cannabis: effects on hunger and thirst. EL Abel, Behav Biol 1975 15 3 255 81 10.1016/S0091-6773(75)91684-3 1106391
5. Endogenous cannabinoid system as a modulator of food intake. D Cota, et al. Int J Obes Relat Metab Disord 2003 27 3 289 301 10.1038/sj.ijo.0802250 12629555
6. The endocannabinoid system: a general view and latest additions. L De Petrocellis MG Cascio V Di Marzo, Br J Pharmacol 2004 141 5 765 74 10.1038/sj.bjp.0705666 14744801
7. The endocannabinoid system: physiology and pharmacology. F Rodriguez de Fonseca, et al. Alcohol Alcohol 2005 40 1 2 14 15550444
8. Isolation, structure and partial synthesis of an active constituent of hashish. Y Gaoni R Mechoulam, J Am Chem Soc 1964 86 1646 10.1021/ja01062a046
9. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. LA Matsuda, et al. Nature 1990 346 6284 561 4 10.1038/346561a0 2165569
10. Molecular characterization of a peripheral receptor for cannabinoids. S Munro KL Thomas M Abu-Shaar, Nature 1993 365 6441 61 5 10.1038/365061a0 7689702
11. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. AC Howlett, et al. Pharmacol Rev 2002 54 2 161 202 10.1124/pr.54.2.161 12037135
12. Modulation of transmitter release via presynaptic cannabinoid receptors. E Schlicker M Kathmann, Trends Pharmacol Sci 2001 22 11 565 72 10.1016/S0165-6147(00)01805-8 11698100
13. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. WA Devane, et al. Science 1992 258 5090 1946 9 10.1126/science.1470919 1470919
14. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. CC Felder, et al. FEBS Lett 1996 393 2-3 231 5 10.1016/0014-5793(96)00891-5 8814296
15. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. L Hanus, et al. J Med Chem 1993 36 20 3032 4 10.1021/jm00072a026 8411021
16. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. EM Berry R Mechoulam, Pharmacol Ther 2002 95 2 185 90 10.1016/S0163-7258(02)00257-7 12182965
17. Endocannabinoid control of food intake and energy balance. V Di Marzo I Matias, Nat Neurosci 2005 8 5 585 9 10.1038/nn1457 15856067
18. Endocannabinoids in the regulation of appetite and body weight. TC Kirkham, Behav Pharmacol 2005 16 5-6 297 313 10.1097/00008877-200509000-00004 16148436
19. Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies. KA Sharkey QJ Pittman, Sci STKE 2005 2005 277 e15 10.1126/stke.2772005pe15 15798103
20. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. U Pagotto, et al. Endocr Rev 2006 27 1 73 100 10.1210/er.2005-0009 16306385
21. The endocannabinoid system as an emerging target of pharmacotherapy. P Pacher S Batkai G Kunos, Pharmacol Rev 2006 58 3 389 462 10.1124/pr.58.3.2 16968947
22. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. N Jamshidi DA Taylor, Br J Pharmacol 2001 134 6 1151 4 10.1038/sj.bjp.0704379 11704633
23. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. TC Kirkham, et al. Br J Pharmacol 2002 136 4 550 7 10.1038/sj.bjp.0704767 12055133
24. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. C Ravinet Trillou, et al. Int J Obes Relat Metab Disord 2004 28 4 640 8 10.1038/sj.ijo.0802583 14770190
25. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. D Cota, et al. J Clin Invest 2003 112 3 423 31 12897210
26. Anti-obesity effect of SR14 a CB1 receptor antagonist, in diet-induced obese mice. C Ravinet Trillou, et al. Am J Physiol Regul Integr Comp Physiol 1716 284 2 345 53
27. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. RW Foltin MW Fischman MF Byrne, Appetite 1988 11 1 1 14 10.1016/S0195-6663(88)80017-5 3228283
28. Cannabinoids and appetite stimulation. RD Mattes, et al. Pharmacol Biochem Behav 1994 49 1 187 95 10.1016/0091-3057(94)90475-8 7816872
29. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. CM Williams TC Kirkham, Psychopharmacology (Berl) 1999 143 3 315 7 10.1007/s002130050953 10353436
30. Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. JE Koch, Pharmacol Biochem Behav 2001 68 3 539 43 10.1016/S0091-3057(01)00467-1 11325410
31. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome. VK Vemuri DR Janero A Makriyannis, Physiol Behav 2008 93 4-5 671 86 10.1016/j.physbeh.2007.11.012 18155257
32. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. M Bensaid, et al. Mol Pharmacol 2003 63 4 908 14 10.1124/mol.63.4.908 12644592
33. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Y Arita, et al. Biochem Biophys Res Commun 1999 257 1 79 83 10.1006/bbrc.1999.0255 10092513
34. Adiponectin: A novel adipokine linking adipocytes and vascular function. BJ Goldstein R Scalia, J Clin Endocrinol Metab 2004 89 6 2563 8 10.1210/jc.2004-0518 15181024
35. The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. I Esposito, et al. Mol Pharmacol 2008 18801918
36. CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant. AJ Scheen, J Neuroendocrinol 2008 20 Suppl 1 139 46 10.1111/j.1365-2826.2008.01681.x 18426513
37. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. YL Liu, et al. Int J Obes (Lond) 2005 29 2 183 7 10.1038/sj.ijo.0802847 15558076
38. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. D Osei-Hyiaman, et al. J Clin Invest 2005 115 5 1298 305 15864349
39. Endogenous cannabinoids and appetite. TC Kirkham CM Williams, Nutr Res Rev 2001 14 1 65 86 10.1079/095442201108729141 19087417
40. Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity. D Cota, et al. J Endocrinol Invest 2003 26 10 1041 4 14759080
41. The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant. AL Murro, Diabetol Metab Syndr 2009 1 1 18 10.1186/1758-5996-1-18 19835615
42. Max Planck Institute of Psychiatry. News Release - Max Planck Society 2002 17